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Abstract 
BACKGROUND: Type 2 diabetes mellitus (T2DM) is a chronic disease which afflicts a large number of people all 
over the world and causes numerous complications to the patients and decreases the quality of their lives. The 
present study was carried out in order to investigate the lived experiences of patients with T2DM. 
METHODS: The present study was carried out by a qualitative method. To collect the required data, in-depth semi-
structured interviews were carried out with 10 patients with T2DM who referred to Bli Hospital in Mergasour 
District, the Kurdistan Region of Iraq, in 2018. The interviews were transcribed and analyzed using Van Manen’s 
(1990) hermeneutic phenomenological method, and the themes were retrieved. 
RESULTS: Based on the results of analyzing the interviews, it was seen that the patients referred to DM as a 
disease that cannot be treated, which was labelled as “incurable disease”. They also referred to the fact that DM 
had made their life very hard, which was labelled as “difficult life”. Moreover, they stated that DM was a silent 
killer, which was labelled as “silent disease”. Finally, they referred to taking insulin shot as addictive, which was 
referred to as “problem with taking insulin”. 
CONCLUSION: According to the results, the patients’ lived experiences were interpreted as incurable disease, 
difficult life, and silent disease, which requires social and individual support to be tackled. Moreover, alternative 
medicines should be figured out because insulin injection was referred to as addictive. The results of the present 
study can be utilized by clinical trials focusing on treating and helping patients with T2DM and enhancing the 
quality of their lives. 
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Introduction1 
As a chronic complex condition, diabetes 
mellitus (DM) has been reported to afflict 
almost all populations all over the world.1 It is 
characterized by high levels of blood sugar 
resulting from the body’s failure to produce or 
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use insulin effectively.2 This disease can be 
associated with numerous complications 
including gangrenous feet, cerebrovascular 
disease, coronary heart disease (CHD), 
retinopathy, and nephropathy.3 
According to International Diabetes 
Federation (IDF) (2013), there are three types 
of DM namely type 1 DM (T1DM), type 2 DM 
(T2DM), and gestational DM (GDM). In T1DM, 
the pancreas cannot produce insulin. In T2DM, 
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or the produced insulin cannot be processed. 
In GDM, the insulin produced during 
pregnancy is not effective enough.4 As 
reported by World Health Organization 
(WHO) (2013), T2DM is the most common type 
of DM and accounts for 90% of DM cases 
worldwide.1 For the purpose of the present 
study, T2DM is focused on. 
T2DM is associated with various symptoms 
including skin infections, genital itchiness, 
stomach pains and constipation, polydipsia 
(excessive thirst), fatigue, polyuria (frequent 
urination), and blurred vision due to dry lens 
of the eye.5 However, these symptoms are 
almost unrecognizable; therefore, this type of 
DM is called silent killer.6 
Research has indicated that there are more 
than 500 million cases of T2DM worldwide and 
it is estimated that its prevalence will increase 
over the next 10 years.7 According to the reports 
published by IDF (2017), prevalence of DM in 
Iraqi adults was 7.5% with 1411500 cases in 
2017.8 The increasing prevalence of DM has 
been attributed to prevalence of obesity and 
low socio-economic status.9  
T2DM can have various negative effects on 
the patients’ lives. For example, life expectancy 
among patients with T2DM is reported to be 15 
years shorter than others.10 Patients with DM 
have been reported to suffer from various 
psychological complications including anxiety, 
depression, sexual dysfunction, or eating 
disorders.11-13 In addition to the mentioned 
psychological complications, DM can lead to 
numerous physiological problems including 
pain in the legs, toes, feet, arms, hands or 
fingers, numbness, indigestion, wasting of the 
feet or hand muscles, urination problems, 
nausea or vomiting, constipation, diarrhea, 
and dizziness.14 
Given the abovementioned complications 
and problems caused by T2DM, quality of life 
among patients with the disease can be 
negatively affected.15,16 In this regard, research 
has suggested that a range of factors such as 
attitudes, available healthcare, biology, and 
behavior can be effective in controlling DM 
and its associated complications.17 Most 
studies dealing with T2DM have focused on 
the causes and therapy methods;16,18,19 
however, effectiveness of the proposed 
therapies depends on the patients’ personal 
characteristics, experiences, life conditions, and 
requirements.20,21 Therefore, it is highly 
significant to achieve deep understanding of 
the lived experiences of patients with T2DM in 
order to provide them with better healthcare 
services and improve the quality of their lives. 
In this regard, the present qualitative study 
was aimed at investigating into the lived 
experiences of patients with T2DM who 
referred to Bli Hospital in Mergasour District, 
the Kurdistan Region of Iraq, in 2018. 
Materials and Methods 
Study design: In order to carry out the present 
study, a qualitative method using Van 
Manen’s hermeneutic phenomenological 
method was employed.22 
Participants: The study sample consisted of 
10 patients with T2DM who had referred to Bli 
Hospital in Mergasour District in 2018. They 
were selected by a convenience sampling 
method. The patients were chosen based on 
some inclusion criteria such as being officially 
diagnosed with T2DM, lack of other chronic 
diseases, and willingness to participate in the 
study. Some of the patients who referred to the 
hospital were not included in the study based 
on the exclusion criteria such as having other 
chronic diseases and lack of willingness to 
participate in the investigation. The 
participants were 6 men and 4 women with an 
age range of 38 to 56 years. They were all from 
Mergasour District. Table 1 presents the 
patients’ socio-demographic and clinical data. 
Data collection: In order to collect the required 
data, in-depth semi-structured interviews were 
carried out with the participants from 
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Table 1. Socio-demographic and clinical data  
of patients 
Socio-demographic and clinical variables n (%) 
Sex 
Female 4 (40) 
Male 6 (60) 
Age (year) 
30-40 4 (40) 
41-50 4 (40) 
51-60 2 (20) 
Place of residence 
Urban 7 (70) 
Rural 3 (30) 
Education level 
Illiterate 3 (30) 
Primary 2 (20) 
High school 3 (30) 
University 2 (20) 
Religion Islam 10 (100) 
Ethnicity Kurdish 10 (100) 
Employment 
Employed 6 (60) 
Unemployed 4 (40) 
Disease duration (year) 
< 5 6 (60) 
> 5 4 (40) 
Current treatment 
Insulin injection 8 (80) 
Metformin 2 (20) 
 
All of the interviews were conducted in a 
relaxing small room at Bli Hospital. In order to 
elicit as much information as possible from the 
participants, friendly relationship was 
established with them, and they were ensured 
that their information would be confidential. 
Moreover, they were given sufficient time to 
consider and answer the questions raised by 
the interviewers. Also, the women were 
interviewed by a female interviewer and the 
men by a male interviewer in order for the 
patients to feel more comfortable and relate 
their lived experiences with more details. The 
interviews were led by asking predetermined 
questions beginning with general questions 
such as “How is it like to suffer from type  
2 diabetes (T2DM)?”, “When did you notice 
you had T2DM? How did it feel?”, or “What is 
it like to have T2DM?” followed by more 
specific questions such as “How has T2DM 
changed your life?” or “What have been the 
effects of T2DM on your daily life?”. Each 
interview lasted for about 55-70 minutes. 
Following the participants’ permission, all 
interviews were recorded and then transcribed 
and translated for further analysis. 
Data analysis: In order to analyze the 
transcript of the interviews, the six 
methodological activities proposed by Van 
Manen (1990)22 were employed (Table 2). 
In order to make sure about the accuracy of 
the translated transcripts, they were compared 
to the recorded interviews several times. 
Afterwards, the themes depicting the patients’ 
lived experiences were extracted by breaking 
down the interviews into words, phrases, and 
sentences by utilizing holistic, detailed, and 
selective approaches. The transcripts were 
reread and scrutinized several times in order 
to thoroughly understand the experiences of 
patients with T2DM. 
 
Table 2. Six methodological activities in Van Manen’s method 
# Van Manen’s methodical activities The researchers’ activities 
1 Turning to the nature of lived experience 
Given the high prevalence of T2DM in the region and its negative 
effects on the patients’ quality of life and finally the need for 
developing effective approaches to improve the patients’ daily 
lives, the researchers decided to carry out an investigation into the 
lived experience of the patients with T2DM. 
2 Investigating experience as we live it Selecting the patients with T2DM 
3 
Reflecting on the essential themes which 
characterize the phenomenon 
Using thematic analysis 
4 
Describing the phenomenon through the art 
of writing and rewriting 
Writing and rewriting to create a phenomenological text 
5 
Maintaining a strong and oriented relation to 
phenomenon 
Discussing the themes in relation to the phenomena 
6 
Balancing the research context by 
considering parts and whole 
Moving between transcripts and themes 
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Trustworthiness: In qualitative studies, the 
level of adequacy or soundness is referred to 
as trustworthiness.23 To ensure trustworthiness 
of a qualitative study, it is necessary to 
describe the data analysis procedure and 
justify the reliability of the results.24 The 
trustworthiness in the present investigation 
was ensured by establishing a good 
relationship with the patients and obtaining 
their trust, benefiting from the comments 
made by the field experts, conducting the 
interviews at suitable time and place, and 
going over the transcripts for several times. In 
addition, the researchers have been active 
nurses in the field for years; therefore, their 
reliability can be ensured. 
Ethical considerations: In order to make sure 
about the observation of the ethical 
considerations, necessary approval was 
obtained from the Ethics Committee of College 
of Medicine, Hawler Medical University, Erbil, 
Iraq (No. 4 on 12-11-2018). Furthermore, the 
study’s objectives, data collection method, and 
confidentiality of the collected information 
were explained to the participants. Moreover, 
the participants were given the right to quit the 
study whenever they wanted to. In addition, 
informed written consent was obtained from 
the patients. In order to keep the collected data 
anonymous, each patient was given a unique 
code (patient 1, patient 2, etc.), and the 
confidentiality of the data was ensured by 
keeping the files containing the collected data 
in a safe place. 
Results 
Analyzing the patients’ lived experiences led 
to elicitation of 4 main themes namely 
“incurable disease”, “difficult life”, “silent 
disease”, and “problem with taking insulin”. 
Incurable disease 
Most of the participants were fed up with 
their frequent referral to physicians and 
hospitals and referred to the fact that their 
disease was untreatable. In this regard, patient 2 
stated: “Since I was diagnosed with diabetes, I have 
been always in hospitals and clinics. I have taken so 
many medicines, and I’m really tired of taking 
medicine. I want to get rid of this disease, but I know 
that there is no final cure for it, and it’s so sad to 
have an incurable disease.” 
Referring to having taken various medicines 
to control his blood glucose, patient 6 said: “My 
blood sugar cannot be controlled by any means. I 
don’t eat much, and I take all medicine prescribed by 
my doctor, but my blood sugar is still very high. My 
disease cannot be cured. It’s so frustrating and 
worrying.” 
Being completely frustrated and tired of 
taking medication and losing hope, patient 8 
revealed: “I’ve been on medication for more than 5 
years, but there has been no sign of being cured 
forever. I’m sure there is no final treatment. I know 
this disease will be with me until I die. Death is the 
only cure for it.” 
Difficult life 
The second theme that emerged from the 
patients’ lived experiences was their difficult 
life conditions. In this regard, patient 3 said: “I 
haven’t enjoyed my life at all since I was diagnosed 
with this disease. My life is full of worry and 
concern about my future. It’s so difficult to live 
with such a disease.” 
Regarding difficult life conditions, 
participant 7 stated: “Living with diabetes is the 
most difficult thing ever. It has affected all aspects 
of my personal, social, and familial life. When 
you’re suffering from diabetes, you no more enjoy 
your life like ordinary people, you always need to be 
careful about what you do and what you eat, and 
it’s really saddening.” 
Also, patient 10 said: “Diabetes has made my 
life so difficult. Apart from all worry and concern it 
has given me, I can’t live like a normal person 
anymore. Since I was diagnosed with it, everything 
in my life has changed, my eating and my sleeping 
habits, my free time activities, and so forth.” 
Silent disease 
The third theme that the patients referred to 
was the fact that T2DM is labeled as a silent killer 
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the early stages until serious complications start 
to appear. In this regard, patient 1 said: “Few 
years ago, everything was ok with me, I didn’t feel any 
pain, but for a while I started to feel so tired and 
restless, my body was so itchy, I had constipation 
almost all the time, so I went to the doctor, and I was 
diagnosed with diabetes. I was told that I had the 
disease many years ago, and I was so shocked.” 
In the same regard, patient 5 said: “It’s so 
difficult to be told that you have had a disease for 
many years, but you haven’t noticed. It’s really 
unbelievable. I wish I had never known I had the 
disease.” 
Also, patient 4 said: “Seemingly, I had no 
problem and I was quite well until that really sad 
thing happened. I lost two of my sons. I underwent a 
mental trauma, and right after that, I was diagnosed 
with type 2 diabetes. I don’t know how I have 
developed that nasty disease.” 
Problem with taking insulin 
The last theme that was obtained from 
analyzing the patients’ lived experiences was 
the fact that they had problem with taking 
insulin as a medicine. In this regard, patient 9 
said: “I think that I’m addicted to insulin. Every 
time I inject insulin, I feel that my body needs 
more, and when I intentionally postpone my 
injection, my body starts wanting it. I prefer to take 
some oral medication.” 
Discussion 
As a result of analyzing the transcripts of the 
interviews carried out with the participating 
patients with T2DM, four main themes  
namely “incurable disease”, “difficult life”, 
“silent disease”, and “problem with taking 
insulin” emerged. 
During the interviews, some of the patients 
revealed their worries about incurability of 
their disease and uncontrollable level of blood 
glucose. In their qualitative study focusing on 
the diabetic patients’ ideas of illness course, 
Lai et al. reported that the participating 
patients considered DM as a chronic incurable 
disease which led to serious complications 
including renal injury, leg amputation, 
blindness, and poor peripheral circulation.25 
Similarly, in relating their experiences with 
DM, the patients participating in the study 
carried out by Natarajan referred to DM as an 
incurable disease.26 Moreover, the patients 
with DM in the study carried out by Selman et 
al. referred to DM as an incurable progressive 
disease.27 The same theme has been reported 
by the study carried out by Abazari et al.28 
The second theme that emerged from 
analyzing the patients’ lived experiences was 
difficult life. By referring to the limitations 
caused by DM, the patients stated that they 
had not enjoyed their lives since their 
diagnosis with T2DM. In their study of 
lifestyle changes as a result of T2DM among 
women from western Sweden, Ahlin and 
Billhult observed that the lifestyle of women 
with DM became more difficult and 
overwhelming,29 which is in line with the 
second theme of the present study. The 
patients participating in the investigation 
carried out by Svedbo Engstrom et al. also 
referred to their hard time dealing with the 
complications and limitations resulting from 
their DM. These patients stated that support 
from others could help them overcome the 
difficulty of dealing with the disease.30 
The third theme that emerged from the 
patients’ lived experiences was silent disease. 
DM has been referred to as a silent disease or 
killer in different studies including those 
carried out by Carolan et al.,31 Abdoli et al.,32 
and DiZazzo-Miller et al.33 Since the 
symptoms of T2DM are not apparent in the 
early stages of the disease until serious 
complications develop, this disease is called a 
silent killer.6 
The final theme emerging from the patients’ 
lived experiences was labeled as problem with 
taking insulin. In this regard, one of the 
patients stated that insulin taking was 
addictive and she preferred to take oral 
medicines. Participants of some previously 
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addictive.34-36 Moreover, in their study of 
exploring Brazilian and Canadian patients’ 
perceptions for insulin therapy in T2DM, 
Guimaraes et al. reported that the patients 
with DM in their study referred to insulin 
injection as drug addiction.37 
There were two limitations in the present 
study. The study setting was the first 
limitation because all of the participants were 
selected from a public hospital in Mergasour 
District, which can have an influence on the 
results and their generalizability to other 
settings particularly to private hospitals where 
patients might have different experiences, 
resulting in different outcomes. Also, the 
participants’ ethnicity and culture made 
another limitation. All of the participants were 
Muslim Kurds with the same culture and 
religion. As a result, the findings may not be 
quite generalizable to other cities and towns in 
the Kurdistan Region and Iraq where Kurds, 
Arabs, and other ethnicities live. 
Conclusion 
The results of the present study indicated that 
while relating their lived experiences, the 
patients with T2DM referred to their experience 
with the disease as “incurable disease”, 
“difficult life”, “silent disease”, and “problem 
with taking insulin”. According to the results, 
future treatments should be based on the 
patients’ lived experiences. In this regard, they 
need to be socially and individually supported 
in order to help them overcome their belief 
about the incurability of their disease, the 
difficulty of their lives, and the silence of the 
disease and its complications. Patients with 
T2DM should also be provided with alternative 
medicines instead of insulin injection. 
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